OliX

팝업닫기

Refusal of Unauthorized Collection of E-mail Addresses

We do not allow the unauthorized collection of e-mail addresses listed on our website.Persons engaging in unauthorized collection with e-mail address collection programs or other technical devices will be subject to criminal prosecution in accordance with the Act on Information & Communications Network Utilization and Information Protection.

Contact Us

form mail list
Name *
Tel *	- -
E-mail *	@
Subject *
Contents
File1
File2
Spam Check*	* 왼쪽의 자동등록방지 코드를 입력하세요.

Consent to Collect and Use Personal Information

I agree to the use of personal information collected from myself or other legitimate sources.

Information collected : Name, Phone number, E-mail, Message
Purpose of collection and use : conducting certain services or activities including but not limited to replying to inquiries and maintaining business records.
Period of retention and use : Personal information is to be discarded after the purpose of collection and use has been achieved.

- Personal Information shall be discarded without delay once the purpose of collection and use has been achieved; provided however that, if an obligation to retain such information exists under applicable law(s), the information shall be retained for a period of time as required by such law(s).
- Even prior to the purpose of use and collection being achieved, personal information may be discarded upon request via email sent to olixpharma@olixpharma.com. Please note, however, that your use of the services herein may be limited.

※ You have the right not to consent to the collection and use of your personal information, in which event your use of the services may be limited.

I agree to the terms and conditions.

Platform Technology

RNAi platform development

Lead compound discovery

Pulmonology / Neurology

Pharmacological research on OliX RNAi compounds for respiratory and neurological diseases

Ophthalmology

Pharmacological research on OliX RNAi compounds for ocular diseases

Animal Research

Testing efficacy of oligonucleotide therapeutics using animal models

Analytics

Develop analytical methods for therapeutic candidates to determine purity and stability in support of nonclinical and clinical studies

PK/TK

Develop bioanalytical methods to quantitate therapeutic candidates in biological matrices for pharmacokinetic and toxicokinetic (PK/TK) studies

CMC

Manage manufacturing, analytics and quality of therapeutic candidates

Toxicology

Conduct safety evaluation and toxicokinetic assessment of therapeutic candidates through nonclinical studies

Clinical

Establish clinical development plans for therapeutic candidates and conduct clinical studies

Management

Business Management

Purchasing

General Affairs

Facility Management

Contingency Planning

Planning

Budget/Performance Management

Mid to Long-term Business Goals/Strategy Planning

Accounting & Finance

Make official announcements about business contents, financial condition, business performance etc.

Stabilize Internal Accounting Control System

IT

IT Infrastructure Management

IT Helpdesk

Human Resources

HR Policy/System Establishment, Organization/Job Design

Recruitment/HR Management

Performance Management, Employee Welfare

HR Development

Legal Affairs

Prevent, respond, handle legal disputes

Provide risk management and compliance support

Develop IP strategies for core technologies

Quality Assurance(QA)

Verify pharmaceutical R&D processes and results

Ensure product to meet the established quality standards

Business Development

Develop/Maintain Client Relationships

Execute Licensing Agreements

New Business/Strategy Planning

Communications

Provide investment information in a timely manner to increase company value

Promote management activities and establish internal/external communication strategies

Create positive corporate culture through various in-house activities and employee education

Home
IR

IR

Stock Information

Stock Information

2023/03/27 16:22:44 (장마감)

· Stock Information

- A226950
  OliX
- Now 22,050
- Change ▼850(-3.71%)
- Volume 144,136
- Value 3,159,569,800

Current	22,750	Upper Limit		29,750
High	22,850	Lower Limit		16,050
Low	21,300	Par Value		500
PER	0.00	52 week	High	29,250
Listed Stocks	13,703,160	52 week	Low	16,750

· Price

Ask Size	A&B	Bid Size
935	22,300
2	22,250
320	22,200
15	22,150
46	22,100
	22,050	684
	22,000	4,132
	21,950	318
	21,900	802
	21,850	730
1,318	Total	6,666

· Hourly Prices

Time	Close(￦)	Change	Ask Price	Bid Price	Volume
15:30:00	22,050	850	22,100	22,050	594
15:20:00	22,050	850	22,100	22,050	30
15:19:40	22,100	800	22,150	22,050	14
15:19:30	22,050	850	22,150	22,050	159
15:18:40	22,150	750	22,150	22,050	99
15:18:00	22,150	750	22,150	22,050	82
15:17:50	22,150	750	22,150	22,100	51
15:17:30	22,150	750	22,150	22,050	10
15:16:40	22,150	750	22,150	22,050	245
15:16:10	22,100	800	22,150	22,100	6

· Daily Prices

Date	Close(￦)	Change	Current	High	Low	Volume	Value
23/03/27	22,050	850	22,750	22,850	21,300	144,136	3,159,569,800
23/03/24	22,900	0	22,900	23,550	22,700	55,977	1,293,334,250
23/03/23	22,900	700	23,400	24,000	22,650	78,129	1,804,415,550
23/03/22	23,600	100	23,800	24,050	23,250	58,304	1,376,288,650
23/03/21	23,700	100	24,200	25,000	23,700	154,838	3,781,335,100
23/03/20	23,600	200	24,050	24,600	23,350	70,376	1,674,351,700
23/03/17	23,800	1,350	22,450	23,950	22,150	122,386	2,874,349,500
23/03/16	22,450	250	22,350	23,000	21,800	58,100	1,299,459,450
23/03/15	22,700	1,550	21,850	22,950	21,550	91,815	2,046,084,800
23/03/14	21,150	1,600	22,700	22,700	21,100	124,898	2,702,711,700